Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
Authors
Keywords
TWEAK/Fn14 axis, Prostate cancer, Biomarkers, Diagnosis, Biofluids
Journal
Journal of Translational Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-09
DOI
10.1186/s12967-019-2053-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
- (2019) Yuan Cheng et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone
- (2017) Hernan Roca et al. JOURNAL OF CLINICAL INVESTIGATION
- SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers
- (2017) Corinna Altenberger et al. Molecular Cancer
- Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall Survival for Metastatic Castration-Resistant Prostate Cancer Patients
- (2016) Daniel C. Danila et al. CANCER JOURNAL
- Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcome
- (2016) Ben Boursi et al. EUROPEAN JOURNAL OF CANCER
- The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA
- (2016) Katherine Fleshner et al. Nature Reviews Urology
- Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity
- (2016) Victor Laurent et al. Nature Communications
- TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion
- (2016) Cheryl L. Armstrong et al. Oncotarget
- Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies
- (2015) L. YuPeng et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma
- (2015) Ximena Terra et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Is PSA related to serum cholesterol and does the relationship differ between black and white men?
- (2015) Daniel Zapata et al. PROSTATE
- CXCL5 Promotes Prostate Cancer Progression
- (2015) Lesa A Begley et al. NEOPLASIA
- AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis
- (2014) J. Yin et al. CANCER RESEARCH
- Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer
- (2014) Francesc Xavier Avilés-Jurado et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- The Rise of Soluble TWEAK Levels in Severely Obese Subjects After Bariatric Surgery May Affect Adipocyte-Cytokine Production Induced by TNFα
- (2013) Elsa Maymó-Masip et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
- (2012) Catharina Medrek et al. BMC CANCER
- Soluble CD163: a biomarker linking macrophages and insulin resistance
- (2012) T. Parkner et al. DIABETOLOGIA
- Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells
- (2012) Ana Belen Sanz et al. PLoS One
- Tumor markers in prostate cancer I: Blood-based markers
- (2011) Shahrokh F. Shariat et al. ACTA ONCOLOGICA
- Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome
- (2011) Mingguo Huang et al. CARCINOGENESIS
- Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores
- (2011) Alberto Briganti et al. EUROPEAN UROLOGY
- Soluble CD163
- (2011) Holger J. Møller SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Serum Soluble CD163 Predicts Risk of Type 2 Diabetes in the General Population
- (2010) H. J. Moller et al. CLINICAL CHEMISTRY
- The CD163-expressing macrophages recognize and internalize TWEAK
- (2009) Juan A. Moreno et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation